Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-12-21

FDA Approved: ISENTRESS — Original Application (Merck Sharp & Dohme LLC)

View source ↗

Summary

FDA approved ISENTRESS (raltegravir) in its original application for HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isentress (Raltegravir)

Snippet

ORIG AP for ISENTRESS (RALTEGRAVIR)